Metagenomic strain detection with SameStr: identification of a persisting core gut microbiota transferable by fecal transplantation

被引:29
|
作者
Podlesny, Daniel [1 ]
Arze, Cesar [1 ,2 ]
Doerner, Elisabeth [1 ]
Verma, Sandeep [3 ]
Dutta, Sudhir [3 ]
Walter, Jens [4 ,5 ]
Fricke, W. Florian [1 ,6 ]
机构
[1] Univ Hohenheim, Dept Microbiome Res & Appl Bioinformat, Stuttgart, Germany
[2] Ring Therapeut, Cambridge, MA USA
[3] Sinai Hosp Baltimore, Div Gastroenterol, Baltimore, MD USA
[4] Univ Coll Cork, Sch Microbiol, APC Microbiome Ireland, Cork, Ireland
[5] Univ Coll Cork, Dept Med, Cork, Ireland
[6] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA
关键词
TRANSMISSION; STABILITY; REVEALS;
D O I
10.1186/s40168-022-01251-w
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: The understanding of how microbiomes assemble, function, and evolve requires metagenomic tools that can resolve microbiota compositions at the strain level. However, the identification and tracking of microbial strains in fecal metagenomes is challenging and available tools variably classify subspecies lineages, which affects their applicability to infer microbial persistence and transfer. Results: We introduce SameStr, a bioinformatic tool that identifies shared strains in metagenomes by determining single-nucleotide variants (SNV) in species-specific marker genes, which are compared based on a maximum variant profile similarity. We validated SameStr on mock strain populations, available human fecal metagenomes from healthy individuals and newly generated data from recurrent Clostridioides difficile infection (rCDI) patients treated with fecal microbiota transplantation (FMT). SameStr demonstrated enhanced sensitivity to detect shared dominant and subdominant strains in related samples (where strain persistence or transfer would be expected) when compared to other tools, while being robust against false-positive shared strain calls between unrelated samples (where neither strain persistence nor transfer would be expected). We applied SameStr to identify strains that are stably maintained in fecal microbiomes of healthy adults over time (strain persistence) and that successfully engraft in rCDI patients after FMT (strain engraftment). Taxonomy-dependent strain persistence and engraftment frequencies were positively correlated, indicating that a specific core microbiota of intestinal species is adapted to be competitive both in healthy microbiomes and during post-FMT microbiome assembly. We explored other use cases for strain-level microbiota profiling, as a metagenomics quality control measure and to identify individuals based on the persisting core gut microbiota. Conclusion: SameStr provides for a robust identification of shared strains in metagenomic sequence data with sufficient specificity and sensitivity to examine strain persistence, transfer, and engraftment in human fecal microbiomes. Our findings identify a persisting healthy adult core gut microbiota, which should be further studied to shed light on microbiota contributions to chronic diseases.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Metagenomic strain detection with SameStr: identification of a persisting core gut microbiota transferable by fecal transplantation
    Daniel Podlesny
    Cesar Arze
    Elisabeth Dörner
    Sandeep Verma
    Sudhir Dutta
    Jens Walter
    W. Florian Fricke
    Microbiome, 10
  • [2] Fecal Microbiota Transplantation and Other Gut Microbiota Manipulation Strategies
    Quaranta, Gianluca
    Guarnaccia, Alessandra
    Fancello, Giovanni
    Agrillo, Chiara
    Iannarelli, Federica
    Sanguinetti, Maurizio
    Masucci, Luca
    MICROORGANISMS, 2022, 10 (12)
  • [3] Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation?
    Cammarota, Giovanni
    Ianiro, Gianluca
    Bibbo, Stefano
    Gasbarrini, Antonio
    INTERNAL AND EMERGENCY MEDICINE, 2014, 9 (04) : 365 - 373
  • [4] Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation?
    Giovanni Cammarota
    Gianluca Ianiro
    Stefano Bibbò
    Antonio Gasbarrini
    Internal and Emergency Medicine, 2014, 9 : 365 - 373
  • [5] Gut microbiota and obesity: implications for fecal microbiota transplantation therapy
    Yongbo Kang
    Yue Cai
    Hormones, 2017, 16 : 223 - 234
  • [6] Gut microbiota and obesity: implications for fecal microbiota transplantation therapy
    Kang, Yongbo
    Cai, Yue
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2017, 16 (03): : 223 - 234
  • [7]  Nanocapsule of gut microbiota for enhancing efficacy of fecal microbiota transplantation
    Hou, Weiliang
    Wang, Jifeng
    Yin, Fang
    Ma, Chunlian
    Wang, Jiahui
    Guo, Ning
    Li, Juanjuan
    Qin, Huanlong
    GUT, 2023, 72 (SUPPL_1) : A68 - A69
  • [8] The role of the gut microbiota and fecal microbiota transplantation in neuroimmune diseases
    Wu, Nan
    Li, Xizhi
    Ma, He
    Zhang, Xue
    Liu, Bin
    Wang, Yuan
    Zheng, Qi
    Fan, Xueli
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [9] Fecal Microbiota Transplantation and Detection of Prevalence of IgA-Coated Bacteria in the Gut
    Zhang, Qiuping
    Lu, Qian
    Luo, Yubin
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2020, (161): : 1 - 15
  • [10] Gut Dysbiosis and Fecal Microbiota Transplantation in Autoimmune Diseases
    Belvoncikova, Paulina
    Maronek, Martin
    Gardlik, Roman
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (18)